These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BET 1: The role of remdesivir in COVID-19 infection. Baombe JP Emerg Med J; 2020 Aug; 37(8):522-523. PubMed ID: 32753375 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection in children with febrile neutropenia. Flores V; Miranda R; Merino L; González C; Serrano C; Solano M; Herrera J; González P; Ruiz G; Saldaña R; Cárdenas A; Chávez-Aguilar LA Ann Hematol; 2020 Aug; 99(8):1941-1942. PubMed ID: 32529285 [No Abstract] [Full Text] [Related]
4. Liver injury in remdesivir-treated COVID-19 patients. Zampino R; Mele F; Florio LL; Bertolino L; Andini R; Galdo M; De Rosa R; Corcione A; Durante-Mangoni E Hepatol Int; 2020 Sep; 14(5):881-883. PubMed ID: 32725454 [No Abstract] [Full Text] [Related]
5. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? Thalha AMM; Lee YY; Besari A; Omar SFS J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289 [No Abstract] [Full Text] [Related]
6. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C Trials; 2020 May; 21(1):422. PubMed ID: 32448345 [TBL] [Abstract][Full Text] [Related]
7. Audio Interview: New Data on Remdesivir in Covid-19. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948 [No Abstract] [Full Text] [Related]
8. [Remdesivir for patients with COVID-19]. Augustin M; Hallek M; Nitschmann S Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516 [No Abstract] [Full Text] [Related]
9. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516 [No Abstract] [Full Text] [Related]
10. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Saha A; Sharma AR; Bhattacharya M; Sharma G; Lee SS; Chakraborty C Arch Med Res; 2020 Aug; 51(6):585-586. PubMed ID: 32439198 [TBL] [Abstract][Full Text] [Related]
11. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient. Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114 [TBL] [Abstract][Full Text] [Related]
12. Antiviral treatment for COVID-19: the evidence supporting remdesivir. Richardson C; Bhagani S; Pollara G Clin Med (Lond); 2020 Nov; 20(6):e215-e217. PubMed ID: 32863273 [TBL] [Abstract][Full Text] [Related]
13. Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19. Jorgensen SCJ; Kebriaei R; Dresser LD Pharmacotherapy; 2020 Jul; 40(7):659-671. PubMed ID: 32446287 [TBL] [Abstract][Full Text] [Related]
14. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. Ison MG; Wolfe C; Boucher HW JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438 [No Abstract] [Full Text] [Related]
15. Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective. Mansuri Z; Shah B; Zafar MK; Jolly T; Jain S Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32470232 [No Abstract] [Full Text] [Related]
16. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit. Sun D AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279 [TBL] [Abstract][Full Text] [Related]